Hanna Wilkman - Stille AB MD CEO

STIL Stock

SEK 228.00 8.00 3.39%

Insider

Hanna Wilkman is MD CEO of Stille AB

Age	56
Phone	46 8 58 85 80 00
Web	https://www.stille.se

Stille AB Management Efficiency

The company has return on total asset (ROA) of 0.0588 % which means that it generated a profit of $0.0588 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1601 %, meaning that it generated $0.1601 on every $100 dollars invested by stockholders. Stille AB's management efficiency ratios could be used to measure how well Stille AB manages its routine affairs as well as how well it operates its assets and liabilities.

Compare Stille AB to Peers

Predict price of Stille AB

Stille AB has accumulated 68.27 M in total debt with debt to equity ratio (D/E) of 0.9, which is about average as compared to similar companies. Stille AB has a current ratio of 3.64, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Stille AB until it has trouble settling it off, either with new capital or with free cash flow. So, Stille AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Stille AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Stille to invest in growth at high rates of return. When we think about Stille AB's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives			INSIDER Age
	Tim Thurn	C Rad AB	42
	Susanne Ahlberg	Genovis AB	66
	Urban Strindlov	CellaVision AB	59
	Julien Veyssy	CellaVision AB	40
	Rikke Rytter	Genovis AB	56
	Ivan Astralaga	C Rad AB	N/A
	Maths hc	CellaVision AB	57
	Annette Colin	Boule Diagnostics AB	N/A
	Xiaodong Wang	C Rad AB	44
	Emelie Gozzi	C Rad AB	N/A
	Christina Hugosson	Boule Diagnostics AB	60
	Simon Ostergaard	CellaVision AB	52
	Nina Wallander	CellaVision AB	49
	Mattias Isaksson	Boule Diagnostics AB	N/A
	Mikael Ekholm	Boule Diagnostics AB	61
	Priscilla Kazumba	C Rad AB	N/A
	Fredrik Olsson	Genovis AB	52
	Karen Bornstein	Boule Diagnostics AB	N/A
	Yve Thorenburg	CellaVision AB	65
	BA BA	Genovis AB	N/A
	Hakan Axelsson	C Rad AB	55

Stille AB manufactures and sells surgical equipment in Sweden and internationally. The company was founded in 1841 and is headquartered in Torshlla, Sweden. Stille AB operates under Medical Equipment classification in Sweden and is traded on Stockholm Stock Exchange. Stille AB (STIL) is traded on Stockholm Exchange in Sweden and employs 100 people.

Management Performance

	Return On Equity	0.16
	Return On Asset	0.0588

Stille AB Management Team

Elected by the shareholders, the Stille AB's board of directors comprises two types of representatives: Stille AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Stille. The board's role is to monitor Stille AB's management team and ensure that shareholders' interests are well served. Stille AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Stille AB's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Niklas Carln, CFO Board
	John Anderson, Head Devel
	Hanna Wilkman, MD CEO

Stille Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Stille AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	0.16
	Return On Asset	0.0588
	Profit Margin	0.10 %
	Operating Margin	0.13 %
	Current Valuation	667.84 M
	Shares Outstanding	5.01 M
	Shares Owned By Insiders	46.70 %
	Shares Owned By Institutions	39.07 %
	Price To Earning	19.85 X
	Price To Book	3.37 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Stille Stock Analysis

When running Stille AB's price analysis, check to measure Stille AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stille AB is operating at the current time. Most of Stille AB's value examination focuses on studying past and present price action to predict the probability of Stille AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stille AB's price. Additionally, you may evaluate how the addition of Stille AB to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC